🔎 Trials Near Me

Akèy › Kansè trakt bilè › Illinois › Chicago

Etid klinik pou Kansè trakt bilè nan Chicago, IL

3 etid pou Kansè trakt bilè ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Ap rekriteFaz 3
  • Research Site, Chicago
  • Research Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07221253

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • University of Illinois Cancer Center, Chicago
  • University of Chicago Medicine, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Ap rekriteFaz 3
  • Research Site, Chicago
Laj 18 a 99 · Tout sèks · Mizajou Aug 19, 2026 · NCT06467357

Etid Kansè trakt bilè nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.